ArticleEuropean heart journal. Case reports2025
Long-term management of aortic stenosis (surgery and transcatheter options in young patients): a case report of valve-in-valve transcatheter aortic valve implantation.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent evidences have supported the use of transcatheter aortic valve implantation (TAVI) across all risk categories of patients. However, in case of young patients several points should be considered in a lifetime perspective taking into account both surgical and percutaneous therapies. Case summary: An 82-year-old man with a history of aortic valve disease treated 12 years earlier with surgical aortic valve and aortic root replacement was admitted for worsening dyspnoea. Echocardiogram showed degenerated surgical bioprosthesis with severe regurgitation. Due to prior surgery and high operative risk, the heart team opted for valve-in-valve TAVI. The procedure was successful and the patient remained asymptomatic at 30-day follow-up. Discussion: This case shows how to approach aortic valve disease in a lifetime perspective. Surgical and percutaneous approaches can be used in multiple combinations according to patient's age, anatomical characteristics and personal preferences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.